Feasibility of sequential therapy with FOLFIRI followed by docetaxel/cisplatin in patients with radically resected gastric adenocarcinoma. A randomized phase III trial. [electronic resource]
Producer: 20071109Description: 341-6 p. digitalISSN:- 1423-0232
- Adenocarcinoma -- drug therapy
- Adolescent
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- adverse effects
- Chemotherapy, Adjuvant -- adverse effects
- Cisplatin -- administration & dosage
- Diarrhea -- chemically induced
- Digestive System Surgical Procedures
- Disease-Free Survival
- Docetaxel
- Drug Administration Schedule
- Feasibility Studies
- Female
- Fluorouracil -- adverse effects
- Humans
- Leucovorin -- adverse effects
- Male
- Middle Aged
- Mitomycin -- administration & dosage
- Neutropenia -- chemically induced
- Prospective Studies
- Stomach Neoplasms -- drug therapy
- Survival Rate
- Taxoids -- administration & dosage
- Thrombocytopenia -- chemically induced
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.